Have a feature idea you'd love to see implemented?
Let us know!
OPK Opko Health Inc
Price (delayed)
$1.55
Market cap
$1.08B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.33
Enterprise value
$1.3B
Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and
Highlights
The debt has decreased by 37% QoQ and by 6% YoY
Opko Health's EPS has decreased by 18% YoY but it has increased by 6% from the previous quarter
The net income is down by 16% year-on-year but it is up by 3.7% since the previous quarter
Opko Health's quick ratio has plunged by 53% YoY and by 28% from the previous quarter
The gross profit has contracted by 41% YoY and by 29% from the previous quarter
Key stats
What are the main financial stats of OPK
Market
Valuations
Earnings
Shares outstanding
697.38M
Market cap
$1.08B
Enterprise value
$1.3B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.77
Price to sales (P/S)
1.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.81
Revenue
$716.37M
EBIT
-$221.97M
EBITDA
-$119.69M
Free cash flow
-$84.1M
Per share
Balance sheet
Liquidity
EPS
-$0.33
Free cash flow per share
-$0.12
Book value per share
$2
Revenue per share
$1.03
TBVPS
$1.13
Total assets
$1.98B
Total liabilities
$584.55M
Debt
$259.49M
Equity
$1.4B
Working capital
$138.43M
Debt to equity
0.19
Current ratio
1.63
Quick ratio
0.66
Net debt/EBITDA
-1.83
Margins
Efficiency
Dividend
EBITDA margin
-16.7%
Gross margin
26%
Net margin
-33.9%
Operating margin
-37.2%
Return on assets
-12.1%
Return on equity
-17.7%
Return on invested capital
-29.4%
Return on capital employed
-12.6%
Return on sales
-31%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPK stock price
How has the Opko Health stock price performed over time
Intraday
-3.13%
1 week
6.16%
1 month
4.03%
1 year
26.02%
YTD
2.65%
QTD
4.03%
Financial performance
How have Opko Health's revenue and profit performed over time
Revenue
$716.37M
Gross profit
$186.11M
Operating income
-$266.6M
Net income
-$243.1M
Gross margin
26%
Net margin
-33.9%
OPK's operating margin has dropped by 94% year-on-year and by 51% since the previous quarter
The operating income has plunged by 60% YoY and by 35% from the previous quarter
The net margin has decreased by 41% YoY and by 7% QoQ
The gross profit has contracted by 41% YoY and by 29% from the previous quarter
Growth
What is Opko Health's growth rate over time
Valuation
What is Opko Health stock price valuation
P/E
N/A
P/B
0.77
P/S
1.51
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.81
Opko Health's EPS has decreased by 18% YoY but it has increased by 6% from the previous quarter
The P/B is 27% below the 5-year quarterly average of 1.1 but 14% above the last 4 quarters average of 0.7
Opko Health's equity has increased by 11% QoQ but it has decreased by 9% YoY
The P/S is 29% above the last 4 quarters average of 1.2 and 11% above the 5-year quarterly average of 1.4
The company's revenue fell by 17% YoY and by 10% QoQ
Efficiency
How efficient is Opko Health business performance
The ROE has decreased by 33% YoY
The ROA has contracted by 26% YoY
OPK's ROIC is up by 19% year-on-year and by 7% since the previous quarter
Opko Health's ROS has decreased by 8% YoY and by 7% from the previous quarter
Dividends
What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPK.
Financial health
How did Opko Health financials performed over time
Opko Health's quick ratio has plunged by 53% YoY and by 28% from the previous quarter
OPK's total liabilities is down by 19% since the previous quarter and by 6% year-on-year
The debt is 81% lower than the equity
The debt to equity is down by 42% since the previous quarter but it is up by 6% year-on-year
The debt has decreased by 37% QoQ and by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.